Brain knowledge and predictors of neuromyths among teachers in Morocco.

Trends Neurosci Educ

Clinical Neurosciences laboratory, Faculty of medicine and pharmacy of Fez, Sidi Mohamed Ben Abdellah University; Neurology Department, Sleep center Hassan II Uneversity Hospital, Sidi Mohamed Ben Abdellah University.

Published: September 2020

The objective of this study was to evaluate brain knowledge and the prevalence of neuromyths among teachers in Morocco. We aimed also predicting factors that may improve teachers' brain knowledge and widespread of neuromyths. An online questionnaire was sent to a large population of Moroccan teachers. The questionnaire contains 32 questions, 20 of them are designed to assess teachers' knowledge about the brain and the remaining 12 questions are neuromyths. The mean score of brain knowledge was (64.34% (SD = 27.9%)) and the mean score of neuromyths was (66.56% (SD= 25.73%)). Besides, 50% of teachers were unable to correctly answer seven out of the 20 brain knowledge questions. Moreover, half of the teachers believed in 9 out of the 12 neuromyths. Knowledge about the brain was the foremost predictor of neuromyths. The study disclosed a real lack of brain knowledge with a widespread of neuromyths among teachers in Morocco.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tine.2020.100135DOI Listing

Publication Analysis

Top Keywords

brain knowledge
24
neuromyths teachers
12
teachers morocco
12
brain
8
neuromyths
8
knowledge widespread
8
widespread neuromyths
8
knowledge brain
8
knowledge
7
teachers
6

Similar Publications

The Brain's Aging Resting State Functional Connectivity.

J Integr Neurosci

January 2025

Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

Resting state networks (RSNs) of the brain are characterized as correlated spontaneous time-varying fluctuations in the absence of goal-directed tasks. These networks can be local or large-scale spanning the brain. The study of the spatiotemporal properties of such networks has helped understand the brain's fundamental functional organization under healthy and diseased states.

View Article and Find Full Text PDF

Evolution of Alzheimer's Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy.

Pharmaceutics

January 2025

Laboratorio Experimental de Enfermedades Neurodegenerativas, Instituto Nacional de Neurología y Neurocirugía, Manuel Velasco Suárez, Mexico City 14269, Mexico.

Alzheimer's disease (AD) represents an escalating global health crisis, constituting the leading cause of dementia among the elderly and profoundly impairing their quality of life. Current FDA-approved drugs, such as rivastigmine, donepezil, galantamine, and memantine, offer only modest symptomatic relief and are frequently associated with significant adverse effects. Faced with this challenge and in line with advances in the understanding of the pathophysiology of this neurodegenerative condition, various innovative therapeutic strategies have been explored.

View Article and Find Full Text PDF

The human microbiota constitute a very complex ecosystem of microorganisms inhabiting both the inside and outside of our bodies, in which health maintenance and disease modification are the main regulatory features. The recent explosion of microbiome research has begun to detail its important role in neurological health, particularly concerning cerebral small vessel disease (CSVD), a disorder associated with cognitive decline and vascular dementia. This narrative review represents state-of-the-art knowledge of the intimate, complex interplay between microbiota and brain health through the gut-brain axis (GBA) and the emerging role of glymphatic system dysfunction (glymphopathy) and circulating cell-derived microparticles (MPs) as mediators of these interactions.

View Article and Find Full Text PDF

Interleukin (IL)-1β is a pro-inflammatory cytokine whose levels are increased in the brains of Alzheimer's disease (AD) patients. Despite the role of IL-1β in the pathology of AD, the fact that it is expressed at very low levels makes it a challenging cytokine to measure, hence limiting its potential use as a reliable biomarker. Moreover, being able to accurately and reliably measure the levels of IL-1 β in blood makes it possible to evaluate this cytokine as a potential biomarker of the inflammatory response in AD.

View Article and Find Full Text PDF

Decoding Codon Bias: The Role of tRNA Modifications in Tissue-Specific Translation.

Int J Mol Sci

January 2025

Department of Neurosurgical Engineering and Translational Neuroscience, Graduate School of Medicine, Tohoku University, Sendai 980-8575, Japan.

The tRNA epitranscriptome has been recognized as an important player in mRNA translation regulation. Our knowledge of the role of the tRNA epitranscriptome in fine-tuning translation via codon decoding at tissue or cell levels remains incomplete. We analyzed tRNA expression and modifications as well as codon optimality across seven mouse tissues.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!